๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cytotoxic Efficacy with Combinations of Topoisomerase I and Topoisomerase II Inhibitors in Sensitive and Multidrugresistant L1210 Mouse Leukemia Cells

โœ Scribed by DALE GRABOWSKI; RAM GANAPATHI


Book ID
111392334
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
99 KB
Volume
803
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Implication of prior treatment with drug
โœ Dr. Kathy S. Albain; Michelle M. Le Beau; Rudolf Ullirsch; Harold Schumacher ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 558 KB

The present case, together with other reports reviewed herein, defines a new subtype of therapy-related acute myeloid leukemia (t-AML). This variant of t-AML is characterized by a short interval from initial drug therapy to bone marrow dysfunction and monocytic morphology without trilineage dysplasi

Interaction of topoisomerase I inhibitor
โœ Roseanne E. Bosciai; Timothy Korbut; Sylvia A. Holden; Gulshan Ara; Beverly A. T ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 576 KB

The cytotoxicity of the topoisomerase-I inhibitors, camptothecin and topotecan, toward the SCC-25 human head-andneck squamous-carcinoma cells and the SCC-25/CDDP sub-line made resistant to cis-diamminedichloroplatinum(ll) was assessed alone and in combination with radiation. Topotecan was less cytot